HO-1-u-1Homo sapiens (Human)Cancer cell line
Also known as: Ueda-1, Ho1u1, HO1u1, HO1U1, Ho-1U1, HO1-U1, HO1-U-1, Ho-1-u-1, HO-1-U-1, HO1-UI
Quick Overview
Human squamous cell carcinoma cell line for cancer research.
Detailed Summary
Research Applications
Key Characteristics
Basic Information
Database ID | CVCL_2784 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Salivary gland, sublingual gland[UBERON:UBERON_0001832] |
Donor Information
Age | 72 |
---|---|
Age Category | Adult |
Sex | Male |
Disease Information
Disease | Squamous cell carcinoma of the oral cavity |
---|---|
Lineage | Head and Neck |
Subtype | Oral Cavity Squamous Cell Carcinoma |
OncoTree Code | OCSC |
DepMap Information
Source Type | RIKEN |
---|---|
Source ID | ACH-002045_source |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Pan-cancer proteomic map of 949 human cell lines.";
Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Cancer Cell 40:835-849.e8(2022).
Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
McDermott U., Garnett M.J., Cheong S.-C.
eLife 9:e57761.1-e57761.34(2020).
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.
Nature 568:511-516(2019).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
A landscape of pharmacogenomic interactions in cancer.";
Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
Cell 166:740-754(2016).
Establishment and first characterization of a sublingual epithelial and immune cell co-culture model.
Vacher G., Sublet E., Gurny R., Borchard G.
Int. J. Pharm. 482:61-67(2015).
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Haber D.A.
Cancer Res. 70:2158-2164(2010).
HO-1-u-1 model for screening sublingual drug delivery -- influence of pH, osmolarity and permeation enhancer.
Wang Y.-F., Zuo Z., Chow M.S.-S.
Int. J. Pharm. 370:68-74(2009).
Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array.
Hamakawa H.
Oncogene 26:5300-5308(2007).
Evaluation of HO-1-u-1 cell line as an in vitro model for sublingual drug delivery involving passive diffusion -- initial validation studies.
Wang Y.-F., Zuo Z., Lee K.K.-H., Chow M.S.-S.
Int. J. Pharm. 334:27-34(2007).
Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium.
Sugiyama M., Bhawal U.K., Dohmen T., Ono S., Miyauchi M., Ishikawa T.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 95:594-600(2003).
Screening the p53 status of human cell lines using a yeast functional assay.
Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Mol. Carcinog. 19:243-253(1997).
Establishment of human tumor cell line (Ueda-1) derived from squamous cell carcinoma of the floor of the mouth.
Miyauchi S., Moroyama T., Sakamoto T., Okamoto T., Takada K.
Nihon Koku Geka Gakkai Zasshi 31:1347-1351(1985).